A major financial dispute involving the U.S. healthcare insurance sector has come to light, with American health insurer Aetna agreeing to a settlement of about 975 crore (approximately $117.7 million) with the U.S. government. The company faced allegations that it secured higher payments under the Medicare program by submitting inaccurate medical diagnosis codes for patients.
The case surfaced following an investigation by the U.S. government and a whistleblower lawsuit. According to the allegations, the company submitted diagnosis codes that did not match patients’ medical records, leading to increased payments from the federal government.
Aetna, however, has not admitted any wrongdoing. The company said the settlement was reached to avoid the uncertainty and high costs associated with prolonged litigation.
The dispute relates to the Medicare Advantage program in the United States. Under this system, patients who opt out of traditional Medicare can enroll in health plans operated by private insurance companies. The government pays these insurers based on the health risk level of enrolled patients.
If a patient is reported to have serious or complex health conditions, insurers receive higher payments to cover treatment costs. This system is known as “risk adjustment,” and the payments depend heavily on diagnosis codes submitted by insurance providers.
exporters knowingly avoided U. S. duties on Asian and European flat-rolled steel products, agreeing to pay $19 million to resolve the dispute, according to a press release issued Wednesday by the U...